Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Ueda

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Diabetes, Obesity & Metabolism|November 21, 2018
Urinary glucose excretion after dapagliflozin treatment: An exposure-response modelling comparison between Japanese and non-Japanese patients diagnosed with type 1 diabetes mellitusVictor Sokolov, Tatiana Yakovleva, Shinya Ueda, et al.
British Journal of Clinical Pharmacology|February 7, 2008
Absolute bioavailability of imidafenacin after oral administration to healthy subjectsTomoya Ohno, Susumu Nakade, Kazuki Nakayama, et al.
Gastrointestinal Cancer Research : GCR|August 14, 2012
Capecitabine plus Cisplatin treatment for advanced gastric cancer in a patient with hepatic impairment secondary to metastasesHisato Kawakami, Shin-Ichi Nishina, Shinya Ueda, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 5, 2012
Tolerability, pharmacokinetics, and pharmacodynamics of the glucokinase activator AZD1656, after single ascending doses in healthy subjects during euglycemic clampHans Ericsson, Daniel Röshammar, Maria Wollbratt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2007
Evaluation of the recommended dose and efficacy of amrubicin as second- and third-line chemotherapy for small cell lung cancerSatoshi Igawa, Nobuyuki Yamamoto, Shinya Ueda, et al.
Biological & Pharmaceutical Bulletin|September 5, 2017
Inhibitory Effects of Juices Prepared from Individual Vegetables on CYP3A4 Activity in Recombinant CYP3A4 and LS180 CellsMasayuki Tsujimoto, Chie Agawa, Shinya Ueda, et al.
International Journal of Clinical Oncology|October 30, 2020
Real-world clinical outcomes and prognostic factors in Japanese patients with recurrent or metastatic squamous cell carcinoma of head and neck treated with chemotherapy plus cetuximab: a prospective observation study (JROSG12-2)Tomoya Yokota, Yosuke Ota, Hirofumi Fujii, et al.
Plant & Cell Physiology|April 4, 2017
Cytochrome P450 Monooxygenase CYP716A141 is a Unique β-Amyrin C-16β Oxidase Involved in Triterpenoid Saponin Biosynthesis in Platycodon grandiflorusKeita Tamura, Yuga Teranishi, Shinya Ueda, et al.
Japanese Journal of Clinical Oncology|July 7, 2010
Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancerShuichi Hironaka, Kentaro Yamazaki, Keisei Taku, et al.
International Journal of Clinical Oncology|August 24, 2022
Real-world clinical outcomes in Japanese patients with locally advanced squamous cell carcinoma of the head and neck treated with radiotherapy plus cetuximab: a prospective observational study (JROSG12-2)Yosuke Ota, Takeshi Kodaira, Hirofumi Fujii, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Diabetes, Obesity & Metabolism|November 21, 2018
Urinary glucose excretion after dapagliflozin treatment: An exposure-response modelling comparison between Japanese and non-Japanese patients diagnosed with type 1 diabetes mellitusVictor Sokolov, Tatiana Yakovleva, Shinya Ueda, et al.
British Journal of Clinical Pharmacology|February 7, 2008
Absolute bioavailability of imidafenacin after oral administration to healthy subjectsTomoya Ohno, Susumu Nakade, Kazuki Nakayama, et al.
Gastrointestinal Cancer Research : GCR|August 14, 2012
Capecitabine plus Cisplatin treatment for advanced gastric cancer in a patient with hepatic impairment secondary to metastasesHisato Kawakami, Shin-Ichi Nishina, Shinya Ueda, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 5, 2012
Tolerability, pharmacokinetics, and pharmacodynamics of the glucokinase activator AZD1656, after single ascending doses in healthy subjects during euglycemic clampHans Ericsson, Daniel Röshammar, Maria Wollbratt, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2007
Evaluation of the recommended dose and efficacy of amrubicin as second- and third-line chemotherapy for small cell lung cancerSatoshi Igawa, Nobuyuki Yamamoto, Shinya Ueda, et al.
Biological & Pharmaceutical Bulletin|September 5, 2017
Inhibitory Effects of Juices Prepared from Individual Vegetables on CYP3A4 Activity in Recombinant CYP3A4 and LS180 CellsMasayuki Tsujimoto, Chie Agawa, Shinya Ueda, et al.
International Journal of Clinical Oncology|October 30, 2020
Real-world clinical outcomes and prognostic factors in Japanese patients with recurrent or metastatic squamous cell carcinoma of head and neck treated with chemotherapy plus cetuximab: a prospective observation study (JROSG12-2)Tomoya Yokota, Yosuke Ota, Hirofumi Fujii, et al.
Plant & Cell Physiology|April 4, 2017
Cytochrome P450 Monooxygenase CYP716A141 is a Unique β-Amyrin C-16β Oxidase Involved in Triterpenoid Saponin Biosynthesis in Platycodon grandiflorusKeita Tamura, Yuga Teranishi, Shinya Ueda, et al.
Japanese Journal of Clinical Oncology|July 7, 2010
Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancerShuichi Hironaka, Kentaro Yamazaki, Keisei Taku, et al.
International Journal of Clinical Oncology|August 24, 2022
Real-world clinical outcomes in Japanese patients with locally advanced squamous cell carcinoma of the head and neck treated with radiotherapy plus cetuximab: a prospective observational study (JROSG12-2)Yosuke Ota, Takeshi Kodaira, Hirofumi Fujii, et al.
Pageof 6